Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
The treatment of overactive bladder (OAB) is still based on antimuscarinics, although the recent introduction of β3 agonists and botulinum toxin A has opened a window of new opport[...]
Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder David Ginsberg, Tim Schneider*, Con Kelleher†, Philip Van Kerrebroeck‡,[...]